Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

3 results about "Isoleucine" patented technology

Isoleucine (symbol Ile or I) is an α-amino acid that is used in the biosynthesis of proteins. It contains an α-amino group (which is in the protonated −NH⁺₃ form under biological conditions), an α-carboxylic acid group (which is in the deprotonated −COO⁻ form under biological conditions), and a hydrocarbon side chain with a branch (a central carbon atom bound to three other carbon atoms). It is classified as a non-polar, uncharged (at physiological pH), branched-chain, aliphatic amino acid. It is essential in humans, meaning the body cannot synthesize it, and must be ingested in our diet. Isoleucine is synthesized from pyruvate employing leucine biosynthesis enzymes in other organisms such as bacteria. It is encoded by the codons AUU, AUC, and AUA.

Valine purification method

ActiveCN101798273AEasy to operateGood choiceIon-exchange process apparatusIon-exchanger regenerationPurification methodsFiltration
The invention relates to a valine purification method, which comprises the following steps: A. adding flocculating agents into valine fermentation liquid for fast precipitating solid impurities, and obtaining primary filter liquid through filtering supernatant; B. adding activated carbon into the primary filter liquid obtained in the step A, wherein the added activated carbon accounts for 1+ / -0.5weight percent of the filter liquid, carrying out stirring and decoloration at 60 + / - 5 DEG C, and then, obtaining secondary filter liquid through filtration; C. using an industrial chromatographic column for separating inorganic salt and heteroacid, and then, using a sodium filter membrane for removing pigment and small molecular impurities to obtain a clear and colorless valine solution; D. concentrating the filter liquid for crystallization to obtain crude valine products; and E. shaking a transmission belt and raising the temperature to 220 + / - 10 DEG C, and carrying out sublimation to remove alanine and isoleucine to obtain pharmaceutical grade competitive valine products. The method has the characteristics of simple operation, good selectivity, cleanness and environment protection, so the yield and the quality of the valine are obviously improved.
Owner:ZHAODONG XINGHU BIOTECHNOLOGY CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products